Publications

Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019. Response to letters regarding “Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period.” Inhal Toxicol 31(11–12):387–391; doi: 10.1080/08958378.2019.1702744. PMID: 31851545.

Sacks NC, Cyr PL, Green S, Healey B, Preib M, Wood D, Pokorney S. Prevalence of patients with paroxysmal supraventricular tachycardia (PSVT) in the United States. Poster presentation, European Society for Cardiology Congress, Paris, France, September 2019.

Frankenfeld CL, Leslie TF. 2019. Descriptive epidemiology of homicides with victim and suspect race or Hispanic ethnicity discordance in the United States: Analysis of National Violent Death Reporting System (NVDRS) 2005-2015. J Interpers Violence 36(17-18):NP9693–NP9173; doi: 10.1177/0886260519861656. PMID: 31288601.

Mease K. Managing immunogenicity in the absence of an ADA assay is no monkey business (case study). Presentation at 25^th annual Charles River Biotech Symposium, Carlsbad, CA, September 2019.

Hoff CE, Movva N, Rosen Vollmar AK, Pérez-Escamilla R. 2019. Impact of maternal anxiety on breastfeeding outcomes: A systematic review. Advanc Nutr 10(5):816-826; doi: 10.1093/advances/nmy132. PMID: 31079143.

Nordyke RJ, Reichert H, Bylsma LC, Jackson JJ, Gage SM, Fryzek J, Roy-Chaudhury P, Lithgow T. 2019. Costs attributable to arteriovenous fistula and arteriovenous graft placements in hemodialysis patients with Medicare coverage. Am J Nephrol 50(4):320-328; doi: 10.1159/000502507. PMID: 31434095.

Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM, Chellman GJ, Balasubramanian G, Monticello TM. 2019. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine. Regul Toxicol Pharmacol 106(Aug):224-238; doi: 10.1016/j.yrtph.2019.05.013. PMID: 31085251.

Webster F, Gagne M, Patlewicz G, Pradeep P, Trefiak N, Judson R, Barton-Maclaren TS. 2019. Predicting estrogen receptor activation by a group of substituted phenols: An integrated approach to testing and assessment case study. Regul Toxicol Pharmacol 106(Aug):278-291; doi: 10.1016/j.yrtph.2019.05.017. PMID: 31121201.

Patlewicz G, Lizarraga L, Rua D, Allen DG, Daniel A, Fitzpatrick SC, Garcia-Reyero N, Gordon J, et al. 2019. Exploring current read-across applications and needs among selected US federal agencies. Regul Toxicol Pharmacol 106(Aug):197-209; doi: 10.1016/j.yrtph.2019.05.011. PMID: 31078681.

Sacks NC, Everson K, Cyr PL, Preib M, Wood D, Pokorney S. Healthcare resource use and expenditures in patients newly diagnosed with paroxysmal supraventricular tachycardia (PSVT) in the United States. Podium presentation, International Society for Pharmacoepidemiology Annual Meetings, Philadelphia, PA, August 2019.

Danese MD, Katz A, Cetin K, Chia V, Gleeson ML, Kelsh M, et al. 2019. Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: An observational cohort study using SEER Medicare data. Leuk Lymphoma 60(8):2015–2024; doi: 10.1080/10428194.2018.1555329. PMID: 30632830.

Thompson CM. The useful chemistry of perfluorinated compounds: Managing safety. The sticky subject of non-stick: Regulatory science challenges of per- and poly-fluorinated compounds (PFAS). Texas A&M University Interdisciplinary Faculty of Toxicology Training Program, 2019 Annual Regulatory Science Symposium, College Station, TX, August 2019.

Andersen ME, Gentry PR, Swenberg JA, Mundt KA, White KW, Thompson C, Bus J, Sherman JH, et al. 2019. Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop. Regul Toxicol Pharmacol 106(Aug):210–223; doi: 10.1016/j.yrtph.2019.04.015. PMID: 31059732.

Fryzek J, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.

Bylsma LC, Levin-Sparenberg E, Lowe K, Sangare L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (MCRC) patients: A systematic literature review and meta-analysis. Poster presented as part of a Spotlight Poster Session at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.

Bylsma LC, Dean R, Lowe K, Sangare L, Alexander D, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis. Poster presented at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.

Buerger AN, Dillon DT, Martyniuk CJ, Bisesi, JH. Gastrointestinal mediated impacts on lipid metabolism following chronic exposure to a phthalate plasticizer in zebrafish. Society of Environmental Toxicology and Chemistry North America Meeting, Durham, NC, 2019.

Ring CL, Rish WR, Brorby GL. Prioritization of eight PFAS by population exposure and reference-dose uncertainty. Poster session at SETAC North America Focused Topic Meeting: Environmental Risk Assessment of PFAS, Durham, NC, August 2019.

Fitch S, van de Ligt J, Payne L, Doepker C, Kleinman R, Handu D, Cohen SM, Anyangwe N, Wikoff D. 2019. Systematic map protocol: A systematic map of the use of acceptable daily intake (ADI) as a health-based benchmark in nutrition research studies that consider the safety of low-calorie sweeteners (LCS). Open Science Framework.

Prior H, Monticello T, Boulifard V, Brennan FR, Kimber I. 2019. Integration of consortia recommendations for justification of animal use within current and future drug development paradigms. Int J Toxicol 38(4):319-325; doi: 10.1177/1091581819852922. PMID: 31220983.